Seelos Therapeutics to Host Key Opinion Leader Call to Discuss Phase I Data and Upcoming Trial Design for SLS-002 - GlobeNewswire

Submitted by Anonymous (not verified) on Mon, 06/15/2020 - 12:07

Seelos Therapeutics to Host Key Opinion Leader Call to Discuss Phase I Data and Upcoming Trial Design for SLS-002  GlobeNewswire